600763 通策医疗
已收盘 12-23 15:00:00
资讯
新帖
简况
通策医疗（600763）披露关于选举职工董事及取消职工监事的公告，12月10日股价下跌0.77%
证券之星 · 12-10
通策医疗（600763）披露关于选举职工董事及取消职工监事的公告，12月10日股价下跌0.77%
通策医疗（600763）披露拟取消监事会并调整公司治理结构，12月03日股价下跌1.31%
证券之星 · 12-03
通策医疗（600763）披露拟取消监事会并调整公司治理结构，12月03日股价下跌1.31%
通策医疗（600763）披露召开2025年第一次临时股东会通知，11月24日股价上涨0.88%
证券之星 · 11-24
通策医疗（600763）披露召开2025年第一次临时股东会通知，11月24日股价上涨0.88%
每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.59%
证券之星 · 11-16
每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.59%
通策医疗：控股股东累计质押持股66.65%
财中社 · 11-11
通策医疗：控股股东累计质押持股66.65%
通策医疗涨5.00%，开源证券二个月前给出“买入”评级
证券之星 · 11-10
通策医疗涨5.00%，开源证券二个月前给出“买入”评级
每周股票复盘：通策医疗（600763）Q3正畸收入增7.9%
证券之星 · 11-02
每周股票复盘：通策医疗（600763）Q3正畸收入增7.9%
股市必读：通策医疗（600763）10月29日披露最新机构调研信息
证券之星 · 10-30
股市必读：通策医疗（600763）10月29日披露最新机构调研信息
通策医疗(600763)9月30日股东户数9.8万户，较上期增加11.17%
证券之星 · 10-28
通策医疗(600763)9月30日股东户数9.8万户，较上期增加11.17%
图解通策医疗三季报：第三季度单季净利润同比增长2.31%
证券之星 · 10-27
图解通策医疗三季报：第三季度单季净利润同比增长2.31%
每周股票复盘：通策医疗（600763）2025上半年归母净利润增3.67%
证券之星 · 10-26
每周股票复盘：通策医疗（600763）2025上半年归母净利润增3.67%
通策医疗（600763）披露2025年半年度业绩说明会召开情况，10月23日股价下跌0.02%
证券之星 · 10-23
通策医疗（600763）披露2025年半年度业绩说明会召开情况，10月23日股价下跌0.02%
通策医疗（600763）股东杭州宝群实业集团有限公司质押225万股，占总股本0.5%
证券之星 · 09-16
通策医疗（600763）股东杭州宝群实业集团有限公司质押225万股，占总股本0.5%
每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.16%
证券之星 · 09-14
每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.16%
通策医疗（600763）披露控股股东部分股票质押及解除质押公告，9月11日股价上涨1.64%
证券之星 · 09-11
通策医疗（600763）披露控股股东部分股票质押及解除质押公告，9月11日股价上涨1.64%
通策医疗（600763）股东杭州宝群实业集团有限公司质押841万股，占总股本1.88%
证券之星 · 09-11
通策医疗（600763）股东杭州宝群实业集团有限公司质押841万股，占总股本1.88%
每周股票复盘：通策医疗（600763）蒲公英分院营收增21%，净利增36%
证券之星 · 08-31
每周股票复盘：通策医疗（600763）蒲公英分院营收增21%，净利增36%
通策医疗：东北证券、华泰证券等多家机构于8月23日调研我司
证券之星 · 08-25
通策医疗：东北证券、华泰证券等多家机构于8月23日调研我司
股市必读：通策医疗中报 - 第二季度单季净利润同比增长0.44%
证券之星 · 08-25
股市必读：通策医疗中报 - 第二季度单季净利润同比增长0.44%
国金证券：给予通策医疗增持评级
证券之星 · 08-24
国金证券：给予通策医疗增持评级
暂无数据
公司概况
公司名称：
通策医疗股份有限公司
所属行业：
卫生
上市日期：
1996-10-30
主营业务：
通策医疗股份有限公司的主营业务是医疗器械、日用品、消毒用品的销售，投资管理，经营进出口业务，技术开发、技术咨询和技术服务，培训服务(不含办培训班)。公司的主要产品是种植、正畸、儿科、修复、大综合。公司连续七年荣膺德勤中国“中国卓越管理公司白金奖”。
发行价格：
4.08
{"stockData":{"symbol":"600763","market":"SH","secType":"STK","nameCN":"通策医疗","latestPrice":40.68,"timestamp":1766473201000,"preClose":41.02,"halted":0,"volume":3053300,"delay":0,"changeRate":-0.0083,"floatShares":447000000,"shares":447000000,"eps":1.1551,"marketStatus":"已收盘","change":-0.34,"latestTime":"12-23 15:00:00","open":40.92,"high":41,"low":40.61,"amount":124000000,"amplitude":0.0095,"askPrice":40.69,"askSize":24,"bidPrice":40.68,"bidSize":162,"shortable":0,"etf":0,"ttmEps":1.1551,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766539800000},"marketStatusCode":5,"adr":0,"adjPreClose":41.02,"symbolType":"stock","openAndCloseTimeList":[[1766453400000,1766460600000],[1766466000000,1766473200000]],"highLimit":45.12,"lowLimit":36.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":447289117,"isCdr":false,"pbRate":4.19,"roa":"--","peRate":35.21773,"roe":"11.8%","epsLYR":1.12,"committee":0.116216,"marketValue":18196000000,"turnoverRate":0.0068,"status":1,"floatMarketCap":18196000000},"requestUrl":"/m/hq/s/600763/tweets","defaultTab":"tweets","newsList":[{"id":"2590538210","title":"通策医疗（600763）披露关于选举职工董事及取消职工监事的公告，12月10日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590538210","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590538210?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:17","pubTimestamp":1765376261,"startTime":"0","endTime":"0","summary":"近日，通策医疗股份有限公司发布关于选举职工董事及取消职工监事的公告。王维倩女士原为非职工董事，本次选举后变更为职工董事，董事会构成人员不变，兼任高级管理人员及职工代表董事人数未超过董事总数的二分之一。公司已根据相关规定取消监事会设置，董事会设职工董事一名。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0114","600763","BK0236","BK0284","BK0048","BK0077","BK0096"],"gpt_icon":0},{"id":"2588042572","title":"通策医疗（600763）披露拟取消监事会并调整公司治理结构，12月03日股价下跌1.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588042572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588042572?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:22","pubTimestamp":1764771742,"startTime":"0","endTime":"0","summary":"截至2025年12月3日收盘，通策医疗报收于41.38元，较前一交易日下跌1.31%，最新总市值为185.09亿元。该股当日开盘41.96元，最高42.0元，最低41.28元，成交额达1.55亿元，换手率为0.84%。此外，公司拟废止《监事会议事规则》，免去现任监事。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300040369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0048","600763","BK0146","BK0284","BK0114","BK0096","BK0077"],"gpt_icon":0},{"id":"2585468756","title":"通策医疗（600763）披露召开2025年第一次临时股东会通知，11月24日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468756?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:58","pubTimestamp":1763978331,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，通策医疗报收于42.23元，较前一交易日上涨0.88%，最新总市值为188.89亿元。该股当日开盘42.15元，最高42.48元，最低41.89元，成交额达1.69亿元，换手率为0.9%。公司近日发布公告称，将于2025年12月10日召开2025年第一次临时股东会，会议采取现场投票与网络投票相结合的方式，股权登记日为2025年12月3日。网络投票将通过上海证券交易所系统进行，现场会议地点位于杭州市西湖区西溪路双口井巷1号通策医疗大厦7楼报告厅。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0284","BK0114","BK0096","BK0146","BK0048","600763","BK0236"],"gpt_icon":0},{"id":"2583651860","title":"每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651860","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651860?lang=zh_cn&edition=full","pubTime":"2025-11-16 03:09","pubTimestamp":1763233751,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，通策医疗报收于44.68元，较上周的42.39元上涨5.4%。本周，通策医疗11月14日盘中最高价报45.59元。11月10日盘中最低价报42.41元。通策医疗当前最新总市值199.85亿元，在医疗服务板块市值排名9/50，在两市A股市值排名974/5165。本次变动后，宝群实业累计质押10103.6672万股，占其所持股份66.65%，占公司总股本22.59%。其一致行动人吕建明持股0.47%，无质押。宝群实业资信良好，具备偿还能力，质押风险可控，不会影响公司控制权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600000719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","600763","BK0146","BK0048","BK0114","BK0236","BK0077","BK0096"],"gpt_icon":0},{"id":"2582352586","title":"通策医疗：控股股东累计质押持股66.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582352586","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582352586?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:01","pubTimestamp":1762851660,"startTime":"0","endTime":"0","summary":"11月11日，通策医疗（600763）发布公告，控股股东杭州宝群实业集团有限公司将其持有的2133万股股份办理质押，占其所持股份的14.07%及公司总股本的4.77%；同时解除质押股份1932万股，占其所持股份的12.74%及公司总股本的4.32%。 截至公告披露日，宝群实业累计质押股份为1.01亿股，占其所持股份的66.65%及公司总股本的22.59%。 2025年前三季度，通策医疗实现收入22.90亿元，归母净利润5.14亿元。（文章来源：财中社）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-11/doc-infwzmka7327171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0284","BK0146","600763","BK0048","BK0077","BK0096","BK0114","BK0236"],"gpt_icon":0},{"id":"2582131823","title":"通策医疗涨5.00%，开源证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2582131823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582131823?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:23","pubTimestamp":1762763035,"startTime":"0","endTime":"0","summary":"今日通策医疗涨5.00%，收盘报44.51元。2025年8月28日，开源证券研究员余汝意,阮帅发布了对通策医疗的研报《公司信息更新报告：2025上半年业绩稳健增长，正畸业务企稳回升》，该研报对通策医疗给出“买入”评级。研报中预计公司2025-2027年归母净利润为5.59/6.10/7.02亿元，当前股价对应PE为37.4/34.2/29.7倍，考虑公司口腔品牌实力及新院开业带来的增量，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的张琎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000020331.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","600763"],"gpt_icon":0},{"id":"2580471835","title":"每周股票复盘：通策医疗（600763）Q3正畸收入增7.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580471835","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580471835?lang=zh_cn&edition=full","pubTime":"2025-11-02 04:52","pubTimestamp":1762030329,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，通策医疗报收于43.45元，较上周的42.02元上涨3.4%。本周，通策医疗10月31日盘中最高价报43.69元。第三季度单季主营收入8.42亿元，同比上升2.34%；归母净利润1.92亿元，同比上升2.31%；扣非净利润1.92亿元，同比上升1.85%。基本每股收益 1.15元，同比增长 3.6%。问：Q3正畸业务增速如何？答：前三季度正畸收入 4.26 亿元，同比增长 7.8%；第三季度单季收入 1.97亿元，同比增长 7.9%，病例量增长 10.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","600763","BK0077","BK0284","BK0146","BK0114","BK0236","BK0048"],"gpt_icon":0},{"id":"2579715573","title":"股市必读：通策医疗（600763）10月29日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2579715573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579715573?lang=zh_cn&edition=full","pubTime":"2025-10-30 07:50","pubTimestamp":1761781827,"startTime":"0","endTime":"0","summary":"截至2025年10月29日收盘，通策医疗报收于42.99元，上涨0.99%，换手率1.27%，成交量5.66万手，成交额2.42亿元。固定矫正与隐形矫正占比分别为83%和17%。公司推进“大部制”改革，设立十大专科医生集团，调整分院院长及科室主任考核机制，强化医生资源配置与门诊量指标，新考核体系预计2026年全面实施。公司2026年战略重心为提升浙江省内市占率，依托现有蒲公英分院布局，强化市场竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000007747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0284","BK0146","600763","BK0048","BK0236","BK0096","BK0114"],"gpt_icon":0},{"id":"2578320936","title":"通策医疗(600763)9月30日股东户数9.8万户，较上期增加11.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578320936","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578320936?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:18","pubTimestamp":1761643092,"startTime":"0","endTime":"0","summary":"户均持股数量由上期的5075.0股减少至4565.0股，户均持股市值为20.1万元。在医疗服务行业个股中，通策医疗股东户数高于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.67万户。从股价来看，2025年6月30日至2025年9月30日，通策医疗区间涨幅为6.69%，在此期间股东户数增加9845.0户，增幅为11.17%。根据统计，通策医疗2025年6月30日至2025年9月30日，主力资金净流出8.98亿元，游资资金净流入3.58亿元，散户资金净流入5.4亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800030787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0096","BK0077","BK0284","BK0114","BK0146","BK0236","600763"],"gpt_icon":0},{"id":"2578614410","title":"图解通策医疗三季报：第三季度单季净利润同比增长2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578614410","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578614410?lang=zh_cn&edition=full","pubTime":"2025-10-27 18:17","pubTimestamp":1761560270,"startTime":"0","endTime":"0","summary":"证券之星消息，通策医疗2025年三季报显示，公司主营收入22.9亿元，同比上升2.56%；归母净利润5.14亿元，同比上升3.16%；扣非净利润5.09亿元，同比上升3.09%；其中2025年第三季度，公司单季度主营收入8.42亿元，同比上升2.34%；单季度归母净利润1.92亿元，同比上升2.31%；单季度扣非净利润1.92亿元，同比上升1.85%；负债率25.1%，投资收益4122.43万元，财务费用3192.82万元，毛利率41.69%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700028225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2578909500","title":"每周股票复盘：通策医疗（600763）2025上半年归母净利润增3.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578909500","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578909500?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:33","pubTimestamp":1761424387,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，通策医疗报收于42.02元，较上周的41.95元上涨0.17%。本周关注点来自公司公告汇总：2025年上半年归母净利润3.21亿元，同比增长3.67%来自公司公告汇总：上海分院预计2025年年底开业来自公司公告汇总：2025年计划新建5家分院来自公司公告汇总：正畸业务收入同比增长7.75%来自公司公告汇总：经营活动现金流净额3.55亿元，同比增长9.7%公司公告汇总通策医疗于2025年10月22日召开半年度业绩说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2577374626","title":"通策医疗（600763）披露2025年半年度业绩说明会召开情况，10月23日股价下跌0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577374626","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577374626?lang=zh_cn&edition=full","pubTime":"2025-10-23 17:18","pubTimestamp":1761211138,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，通策医疗报收于42.19元，较前一交易日下跌0.02%，最新总市值为188.71亿元。公司近日发布公告，披露了2025年半年度业绩说明会的召开情况。公告显示，通策医疗旗下拥有89家医疗机构，专业医疗人员4452名，牙椅3100余台。2025年上半年门诊人次173.22万，同比增长1.21%；营业收入14.48亿元，同比增长2.68%；归母净利润3.21亿元，同比增长3.67%；扣非净利润3.17亿元，同比增长3.9%。浙江省内医疗服务收入12.2亿元，同比增长2.6%。2025年计划新建5家分院。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300026756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0236","BK0284","BK0114","600763","BK0077","BK0096","BK0048"],"gpt_icon":0},{"id":"2567110953","title":"通策医疗（600763）股东杭州宝群实业集团有限公司质押225万股，占总股本0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567110953","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567110953?lang=zh_cn&edition=full","pubTime":"2025-09-16 18:31","pubTimestamp":1758018661,"startTime":"0","endTime":"0","summary":"证券之星消息，通策医疗9月16日公开信息显示，股东杭州宝群实业集团有限公司向中国民生银行股份有限公司杭州分行合计质押225.0万股，占总股本0.5%。质押详情见下表：截止本公告日，股东杭州宝群实业集团有限公司已累计质押股份9847.67万股，占其持股总数的64.96%，股东鲍正梁已累计质押股份700.0万股，占其持股总数的62.09%。通策医疗主营业务：医疗服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600031581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763","BK0048","BK0096","BK0284","BK0114","BK0146","BK0236","BK0077"],"gpt_icon":0},{"id":"2567133130","title":"每周股票复盘：通策医疗（600763）控股股东质押股份占总股本22.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567133130","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567133130?lang=zh_cn&edition=full","pubTime":"2025-09-14 02:30","pubTimestamp":1757788238,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，通策医疗报收于47.36元，较上周的46.45元上涨1.96%。本周关注点公司公告汇总：控股股东宝群实业累计质押股份占公司总股本22.16%。公司公告汇总通策医疗公告，控股股东宝群实业持有公司股份151,589,199股，占总股本33.89%。本次质押8,410,000股，占其所持股份5.55%，占公司总股本1.88%；同时解除质押8,403,570股，占其所持股份5.54%，占公司总股本1.88%。宝群实业及其一致行动人合计持股153,680,287股，已质押股份占其合计持股的64.48%，占公司总股本22.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400000470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","600763","BK0077","BK0284","BK0146","BK0114","BK0236","BK0048"],"gpt_icon":0},{"id":"2566199178","title":"通策医疗（600763）披露控股股东部分股票质押及解除质押公告，9月11日股价上涨1.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566199178","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566199178?lang=zh_cn&edition=full","pubTime":"2025-09-11 22:10","pubTimestamp":1757599845,"startTime":"0","endTime":"0","summary":"截至2025年9月11日收盘，通策医疗报收于47.78元，较前一交易日上涨1.64%，最新总市值为213.71亿元。近日，通策医疗发布关于控股股东部分股票质押及解除质押的公告。公告显示，控股股东宝群实业持有公司股份151,589,199股，占总股本33.89%。本次质押8,410,000股，占其所持股份5.55%，占公司总股本1.88%；同时解除质押8,403,570股，占其所持股份5.54%，占公司总股本1.88%。宝群实业及其一致行动人合计持股153,680,287股，已质押股份占其合计持股的64.48%，占公司总股本22.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100038659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0284","BK0077","600763","BK0114","BK0146","BK0048","BK0236","BK0096"],"gpt_icon":0},{"id":"2566649069","title":"通策医疗（600763）股东杭州宝群实业集团有限公司质押841万股，占总股本1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566649069","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566649069?lang=zh_cn&edition=full","pubTime":"2025-09-11 18:31","pubTimestamp":1757586662,"startTime":"0","endTime":"0","summary":"证券之星消息，通策医疗9月11日公开信息显示，股东杭州宝群实业集团有限公司向中国农业银行股份有限公司杭州西湖支行合计质押841.0万股，占总股本1.88%。质押详情见下表：截止本公告日，股东杭州宝群实业集团有限公司已累计质押股份9909.79万股，占其持股总数的65.37%，股东鲍正梁已累计质押股份700.0万股，占其持股总数的62.09%。通策医疗主营业务：医疗服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100032284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0236","BK0096","BK0048","BK0077","BK0284","BK0114","600763"],"gpt_icon":0},{"id":"2563788205","title":"每周股票复盘：通策医疗（600763）蒲公英分院营收增21%，净利增36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563788205","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563788205?lang=zh_cn&edition=full","pubTime":"2025-08-31 04:15","pubTimestamp":1756584914,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，通策医疗报收于47.14元，较上周的46.74元上涨0.86%。本周关注点机构调研要点：蒲公英48家分院上半年营收3.93亿元，同比增长21%；净利润5368万元，同比增长36%。公司公告汇总：通策医疗拟收购上海存济口腔门诊部100%股权，总对价4600万元，为公司战略进驻上海市场重要举措。今年1-6月，蒲公英48家分院总体营收3.93亿元，同比增长21%；净利润5368万元，同比增长36%；门诊量同比增长23%，符合公司年初预期，有望成为新的业绩增长点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100000585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2562127612","title":"通策医疗：东北证券、华泰证券等多家机构于8月23日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2562127612","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562127612?lang=zh_cn&edition=full","pubTime":"2025-08-25 17:21","pubTimestamp":1756113707,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年8月25日通策医疗发布公告称东北证券叶菁 文将儒 古翰羲、华泰证券代雯 高鹏 杨昌源、开源证券余汝意 阮帅、国盛证券张金洋 胡偌碧 徐雨涵、中信证券陈竹 宋硕 沈睦钧、广发证券罗佳荣 王少喆、招商医药梁广楷 张语馨、天风医药杨松 张雪、东吴医药朱国广 冉胜男 李倩于2025年8月23日调研我司。通策医疗主营业务：医疗服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500023573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1979443071.USD","BK1564","000686","BK0012","BK0028","601688","600763","06886","LU1580142542.USD","BK0146","BK0188","LU1934453819.USD","BK0096","BK0183","BK0284","LU1328615791.USD","BK0276","BK0077","LU1064130708.USD","LU1781817850.SGD","BK1147","LU2148510915.USD","BK0048","LU1064131003.USD","BK0236","BK0114"],"gpt_icon":0},{"id":"2562026741","title":"股市必读：通策医疗中报 - 第二季度单季净利润同比增长0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562026741","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562026741?lang=zh_cn&edition=full","pubTime":"2025-08-25 06:39","pubTimestamp":1756075152,"startTime":"0","endTime":"0","summary":"业绩披露要点通策医疗2025年中报显示，公司主营收入14.48亿元，同比上升2.68%；归母净利润3.21亿元，同比上升3.67%；扣非净利润3.17亿元，同比上升3.85%；其中2025年第二季度，公司单季度主营收入7.04亿元，同比上升0.24%；单季度归母净利润1.37亿元，同比上升0.44%；单季度扣非净利润1.35亿元，同比下降0.22%；负债率27.51%，投资收益2709.12万元，财务费用2107.46万元，毛利率40.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500001284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0},{"id":"2561257756","title":"国金证券：给予通策医疗增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2561257756","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561257756?lang=zh_cn&edition=full","pubTime":"2025-08-24 16:50","pubTimestamp":1756025434,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕近期对通策医疗进行研究并发布了研究报告《业绩平稳增长》，给予通策医疗增持评级。 通策医疗 业绩简评 2025年8月23日，公司发布2025年半年度报告。 经营分析 业绩平稳增长，正畸业务持续复苏。最新盈利预测明细如下：该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为48.12。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400007061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600763"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766486847554,"stockEarnings":[{"period":"1week","weight":0.0191},{"period":"1month","weight":-0.0201},{"period":"3month","weight":-0.0713},{"period":"6month","weight":-0.0002},{"period":"1year","weight":-0.1273},{"period":"ytd","weight":-0.066}],"compareEarnings":[{"period":"1week","weight":0.0128},{"period":"1month","weight":0.0215},{"period":"3month","weight":0.025},{"period":"6month","weight":0.1335},{"period":"1year","weight":0.1631},{"period":"ytd","weight":0.1687}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通策医疗股份有限公司","boardCode":"AI0083","boardName":"卫生","stockholders":"98000人(较上一季度增加8.89%)","perCapita":"4564股","listingDate":"1996-10-30","address":"浙江省杭州市上城区平海路57号","registeredCapital":"44728万元","survey":" 通策医疗股份有限公司的主营业务是医疗器械、日用品、消毒用品的销售，投资管理，经营进出口业务，技术开发、技术咨询和技术服务，培训服务(不含办培训班)。公司的主要产品是种植、正畸、儿科、修复、大综合。公司连续七年荣膺德勤中国“中国卓越管理公司白金奖”。","listedPrice":4.08},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通策医疗,600763,通策医疗股票,通策医疗股票老虎,通策医疗股票老虎国际,通策医疗行情,通策医疗股票行情,通策医疗股价,通策医疗股市,通策医疗股票价格,通策医疗股票交易,通策医疗股票购买,通策医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通策医疗(600763)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通策医疗(600763)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}